SEP 29, 2026 · JOURNAL ARTICLE
Concordance between Tissue- and Plasma-based EGFR Mutation Testing According to Testing Interval in Non-small Cell Lung Cancer
Korean Journal of Clinical Laboratory Science
Testing for epidermal growth factor receptor (EGFR) mutations is essential for selecting targeted therapy in patients with non-small cell lung cancer (NSCLC).This study evaluated t